StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.86−0.44 (-5.30%)

Close on Nov 17, 2026Market cap $251.95MP/E –Yield –

ClearPoint Neuro operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

ClearPoint Neuro's operating cash flow for the twelve months ending Sep 30, 2026 was -$47.14M. For fiscal 2025 it was -$23.90M. The highest annual figure on record is -$2.85M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.90M–
FY2024Dec 31, 2024-$8.95M–
FY2023Dec 31, 2023-$13.72M–
FY2022Dec 31, 2022-$16.17M–
FY2021Dec 31, 2021-$12.70M–
FY2020Dec 31, 2020-$7.81M–
FY2019Dec 31, 2019-$2.85M–
FY2018Dec 31, 2018-$4.63M–
FY2017Dec 31, 2017-$5.99M–
FY2016Dec 31, 2016-$5.82M–
FY2015Dec 31, 2015-$8.64M–
FY2014Dec 31, 2014-$7.25M–
FY2013Dec 31, 2013-$7.78M–
FY2012Dec 31, 2012-$7.43M–
FY2011Dec 31, 2011-$6.24M–
FY2010Dec 31, 2010-$7.71M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$20.10M–
Q2 FY2026Jun 30, 2026-$7.02M–
Q1 FY2026Mar 31, 2026-$7.97M–
Q4 FY2025Dec 31, 2025-$12.06M–
Q3 FY2025Sep 30, 2025-$3.12M–
Q2 FY2025Jun 30, 2025-$2.55M–
Q1 FY2025Mar 31, 2025-$6.17M–
Q4 FY2024Dec 31, 2024-$1.24M–
Q3 FY2024Sep 30, 2024-$1.20M–
Q2 FY2024Jun 30, 2024-$2.67M–
Q1 FY2024Mar 31, 2024-$3.84M–
Q4 FY2023Dec 31, 2023-$1.17M–
Q3 FY2023Sep 30, 2023-$1.80M–
Q2 FY2023Jun 30, 2023-$5.08M–
Q1 FY2023Mar 31, 2023-$5.68M–
Q4 FY2022Dec 31, 2022-$3.07M–
Q3 FY2022Sep 30, 2022-$3.85M–
Q2 FY2022Jun 30, 2022-$4.98M–
Q1 FY2022Mar 31, 2022-$4.27M–
Q4 FY2021Dec 31, 2021-$3.55M–
Q3 FY2021Sep 30, 2021-$3.30M–
Q2 FY2021Jun 30, 2021-$3.72M–
Q1 FY2021Mar 31, 2021-$2.13M–
Q4 FY2020Dec 31, 2020-$2.40M–
Q3 FY2020Sep 30, 2020-$1.37M–
Q2 FY2020Jun 30, 2020-$1.71M–
Q1 FY2020Mar 31, 2020-$2.33M–
Q4 FY2019Dec 31, 2019-$466.30K–
Q3 FY2019Sep 30, 2019-$964.14K–
Q2 FY2019Jun 30, 2019-$810.11K–
Q1 FY2019Mar 31, 2019-$609.46K–
Q4 FY2018Dec 31, 2018-$582.38K–
Q3 FY2018Sep 30, 2018-$975.27K–
Q2 FY2018Jun 30, 2018-$1.11M–
Q1 FY2018Mar 31, 2018-$1.96M–
Q4 FY2017Dec 31, 2017-$1.75M–
Q3 FY2017Sep 30, 2017-$1.68M–
Q2 FY2017Jun 30, 2017-$1.22M–
Q1 FY2017Mar 31, 2017-$1.35M–
Q4 FY2016Dec 31, 2016-$1.11M–

More ClearPoint Neuro figures

See a number that looks wrong?